Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGES | O14684 | 17/20 | 0.95 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.66 |
| ▸ | PLK1 | P53350 | 1/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.54 |
| ▸ | HPGD | P15428 | 1/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.54 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22259994 | 1.00 | PTGES (0.95) | PTGESSIRT2PLK1KDM4EHPGD | |
| SCHEMBL22260235 | 0.97 | PTGES (1.00) | PTGESSIRT2PLK1KDM4EHPGD | |
| SCHEMBL22260242 | 0.93 | PTGES (0.94) | PTGESSIRT2PLK1KDM4EHPGD | |
| SCHEMBL22260237 | 0.93 | PTGES (0.94) | PTGESSIRT2PLK1KDM4EHPGD | |
| SCHEMBL22259989 | 0.91 | PTGES (1.00) | PTGESSIRT2 | |
| SCHEMBL22260001 | 0.91 | PTGES (1.00) | PTGESSIRT2 | |
| SCHEMBL22260243 | 0.91 | PTGES (1.00) | PTGESSIRT2 | |
| SCHEMBL22260230 | 0.90 | PTGES (1.00) | PTGESSIRT2PLK1KDM4EHPGD | |
| SCHEMBL22260245 | 0.88 | PTGES (1.00) | PTGESSIRT2 | |
| SCHEMBL22259948 | 0.85 | PTGES (0.77) | PTGESSIRT2PLK1KMT2ANPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12030877-B2 | Prostaglandin E synthase inhibitors and methods for utilizing the same | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) | 2024-07-09 | — | — | US | disclosed |
| US-11325901-B2 | Prostaglandin E synthase inhibitors and methods for utilizing the same | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) | 2022-05-10 | — | — | US | disclosed |
| US-11220497-B2 | — | — | 2022-01-11 | — | — | US | disclosed |
| US-20200231583-A1 | Prostaglandin E Synthase Inhibitors and Methods for Utilizing the Same | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION | 2020-07-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11325901-B2 | Prostaglandin E synthase inhibitors and methods for utilizing the same | PTGES, PTGS1, PTGES2 | PTGES 1/4885SIRT2 2515/4885PLK1 3258/4885 |
| US-11220497-B2 | — | PTGES, PTGS1, PTGES2 | PTGES 1/4885SIRT2 2795/4885PLK1 3032/4885 |
| US-20200231583-A1 | Prostaglandin E Synthase Inhibitors and Methods for Utilizing the Same | PTGES, PTGS1, PTGES2 | PTGES 1/4885SIRT2 2515/4885PLK1 3258/4885 |
| US-12030877-B2 | Prostaglandin E synthase inhibitors and methods for utilizing the same | PTGES, PTGS1, PTGES2 | PTGES 1/4885SIRT2 2515/4885PLK1 3258/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.